Zealand Pharma A/S
OTC:ZLDPF

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
OTC:ZLDPF
Watchlist
Price: 63.42 USD 1.97% Market Closed
Market Cap: 4.5B USD

Intrinsic Value

ZLDPF's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ZLDPF stock under the Base Case scenario is 15.59 USD. Compared to the current market price of 63.42 USD, Zealand Pharma A/S is Overvalued by 75%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ZLDPF Intrinsic Value
15.59 USD
Overvaluation 75%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Zealand Pharma A/S

Valuation History Unavailable

Historical valuation for ZLDPF cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Zealand Pharma A/S
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zealand Pharma A/S

Current Assets 9B
Cash & Short-Term Investments 8.5B
Receivables 159.9m
Other Current Assets 253.7m
Non-Current Assets 164.1m
PP&E 129.6m
Intangibles 14.1m
Other Non-Current Assets 20.4m
Efficiency

Free Cash Flow Analysis
Zealand Pharma A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zealand Pharma A/S

Revenue
55.7m DKK
Cost of Revenue
-3.7m DKK
Gross Profit
52m DKK
Operating Expenses
-1.5B DKK
Operating Income
-1.4B DKK
Other Expenses
216.3m DKK
Net Income
-1.2B DKK
Fundamental Scores

ZLDPF Profitability Score
Profitability Due Diligence

Zealand Pharma A/S's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
ROE is Increasing
Negative 1-Year Revenue Growth
22/100
Profitability
Score

Zealand Pharma A/S's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

ZLDPF Solvency Score
Solvency Due Diligence

Zealand Pharma A/S's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Zealand Pharma A/S's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZLDPF Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZLDPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZLDPF is 149.32 USD with a low forecast of 116.29 USD and a high forecast of 180.54 USD.

Lowest
Price Target
116.29 USD
83% Upside
Average
Price Target
149.32 USD
135% Upside
Highest
Price Target
180.54 USD
185% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Zealand Pharma A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for ZEAL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

ZLDPF News

Other Videos
What is the Intrinsic Value of one ZLDPF stock?

The intrinsic value of one ZLDPF stock under the Base Case scenario is 15.59 USD.

Is ZLDPF stock undervalued or overvalued?

Compared to the current market price of 63.42 USD, Zealand Pharma A/S is Overvalued by 75%.

Back to Top